4
Changes in Ownership
Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000618
Chief Executive Officer acquired 284,851 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award | +284,851 | 284,851 | D | ||
| Derivatives | |||||||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +99,950 | 99,950 | D | ||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +9,994 | 9,994 | D | ||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +263,400 | 263,400 | D | ||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +460,950 | 460,950 | D | ||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +817,560 | 817,560 | D | ||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +658,500 | 658,500 | D | ||
| Kirkpatrick Lynn Chief Executive Officer | 2021-06-30 | Grant or award · Stock Option | +6,585 | 6,585 | D | ||
Loading xslF345X03/edgar.xml…